Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

HoneyLab Secures Massive USA Distribution, Rename As TRG Natural Pharmaceuticals

Tauranga-based company’s natural pharmaceutical products to hit shelves in all 50 US states

Kiwi natural pharmaceutical company, TRG Natural Pharmaceuticals (formerly HoneyLab), will see its products sold across all 50 states in the US as part of its licencing deal with Taro Pharmaceuticals. This deal is a key contributor to TRG’s 10-20 fold increase in sales this year.

Launched under the brand Bee RX, the range includes topical kānuka honey based cold sore, acne, and rosacea treatments. First launched online at Target, the first drop of product sold out within hours. Bee RX will also be sold in major pharmacy chains, in total representing more than 21,000 stores and giving TRG a strong foothold across every state in the US.

The brand is being fronted by Golden Globe and Emmy nominated actress and singer, Mandy Moore, well-known for the TV show ‘This is Us,’ and Erika Thompson of Texas Bee Works is the Bee RX ambassador.

TRG Natural Pharmaceuticals CEO, Anthony Lawler, says seeing stock on international shelves is a huge achievement for the business.

“Seeing our products on shelves in the US has been a key milestone for TRG. To see Bee RX selling out within hours of going on sale has surpassed our expectations.”

Mr Lawler says the business has navigated the unique challenges of a global pandemic on supply chain management, and business development.

“We have faced our fair share of Covid-19 induced setbacks. Not only have supply chain issues impacted our manufacturing capacity and product distribution timelines, but closing deals and building important relationships with distributors such as Taro can be difficult when you can’t meet face-to-face.”

Diving back into global business

With international travel off the cards for the last 18 months, founder Dr Shaun Holt is travelling to the US in August for two months to support TRG’s rapid expansion into the market. He will also visit Europe until year end to open the door into these territories.

A medical doctor and natural health expert, Dr Holt recently featured on Netflix’s documentary (Un)Well, bringing much international attention as well as praise for his innovation in the health and wellbeing retail space. He was also a finalist in the 2019 EY New Zealand Entrepreneur of the Year awards.

“While we have built strong relationships with licensing partners virtually, video calls can only get you so far. It’s vital for us to continue building relationships and meeting potential new licensing partners face-to-face,” Dr Holt says.

“TRG Natural Pharmaceuticals has ambitious plans to continue expanding globally, and I look forward to showcasing our scientifically-proven New Zealand natural healthcare products in person.”

The evolution to TRG Natural Pharmaceuticals

HoneyLab has changed its name to TRG Natural Pharmaceuticals, having greatly evolved in the past decade. Starting out as HoneyLab and specialising in pharmaceutical-grade, clinically proven honey-based healthcare products, the company is currently best known for its cold sore product, Honevo.

While honey is still important for TRG, the company is now developing other natural ingredients to create clinically proven natural healthcare products.

“The name TRG Natural Pharmaceuticals comes from the airport city code for Tauranga where the company was founded. We needed a name that better aligns to our future plans.”

“The name change represents a need to convey how the company has expanded and to better reflect the pipeline of products currently in development. We look forward to sharing these in due course, Dr Holt concludes.

 

About TRG Natural Pharmaceuticals

TRG Natural Pharmaceuticals (formerly HoneyLab) is a New Zealand pharmaceutical company developing health products from natural sources. The company has undertaken the world’s largest programme of medical honey research. Their patented topical honey formulation, Honevo, is proven in the treatment of cold sores, rosacea and acne, with clinical results published in the acclaimed British Medical Journal Open.

The licence agreement with Taro Pharmaceuticals, TRG Natural Pharmaceuticals’ first large-scale deal, covers the territories of USA, Canada and Israel and covers eight products: the topical kānuka honey range Honevo, the bee venom-based cosmetic range Kanu, and Rubeeven, a natural topical treatment for joint and muscle pain.

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 


R&NTU: KiwiRail strike notices withdrawn following new offer

Strike notices on KiwiRail have been withdrawn. Rail and Maritime Transport Union General Secretary Wayne Butson says following negotiations between the RMTU and KiwiRail, a new offer from KiwiRail will be taken back to union members for ratification... More>>



Banking: Stress Tests Show Strengthening Bank Resilience

The latest stress tests carried out by the Reserve Bank of New Zealand – Te Pūtea Matua show strengthening resilience in the banking sector and the benefits of continuing to build capital buffers... More>>


Statistics: Building Activity Down In September Quarter
The volume of building activity in New Zealand fell 8.6 percent in the September 2021 quarter, compared with the June 2021 quarter, Stats NZ said today. Residential building activity fell by 6.4 percent in the September 2021 quarter, while non-residential building activity fell 12 percent... More>>



Reserve Bank: Deputy Governor Reflects On Time At RBNZ
Central bankers must continue to look forward to guard against the unpredictable, Deputy Governor Geoff Bascand says in a speech published today. Mr Bascand joined the Reserve Bank of New Zealand – Te Pūtea Matua in 2013 during the aftermath of the Global Financial Crisis... More>>


Xero: Data Reveals ICT Expenditure Key To Small Business Sales Growth
Xero, the global small business platform, today released a new report which shows New Zealand small business ICT expenditure has increased 25 percent compared to pre-pandemic levels - more than the UK (20%) and Australia... More>>


Fonterra: Lifts Forecast Farmgate Milk Price Range And Revises Earnings Guidance At First Quarter Update

Fonterra Co-operative Group today lifted its 2021/22 forecast Farmgate Milk Price range, reported a solid start to the 2022 financial year and revised its earnings guidance... More>>


Canterbury Museum: New Research - Bald Haast's Eagle Feasted On Moa Guts

New Zealand’s extinct Haast’s Eagle (Hieraaetus moorei), the largest known eagle, gulped down viscera like a vulture and may even have been bald, new research suggests... More>>